Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant IL4 (Pascolizumab Biosimilar) antibody

This anti-IL4 (Pascolizumab Biosimilar) antibody is a Human Monoclonal antibody detecting IL4 (Pascolizumab Biosimilar) in ELISA, Func, BLI, FACS and SPR. Suitable for Human.
Catalog No. ABIN7675777
-15% Promotion 2026
$294.23
$346.15
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to: United States
Delivery in 10 to 11 Business Days

Quick Overview for Recombinant IL4 (Pascolizumab Biosimilar) antibody (ABIN7675777)

Target

IL4 (Pascolizumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 1
  • 1
  • 1
  • 1
Human

Clonality

  • 2
  • 2
Monoclonal

Conjugate

  • 4
This IL4 (Pascolizumab Biosimilar) antibody is un-conjugated

Application

ELISA, Functional Studies (Func), Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Purpose

    Anti-IL-4 Reference Antibody (pascolizumab)

    Sequence

    QVTLRESGPA LVKPTQTLTL TCTFSGFSLS TSGMGVSWIR QPPGKGLEWL AHIYWDDDKR YNPSLKSRLT ISKDTSRNQV VLTMTNMDPV DTATYYCARR ETVFYWYFDV WGRGTPVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKRVE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K,DIVLTQSPSS LSASVGDRVT ITCKASQSVD YDGDSYMNWY QQKPGKAPKL LIYAASNLES GIPSRFSGSG SGTDFTFTIS SLQPEDIATY YCQQSNEDPP TFGQGTKVEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC

    Characteristics

    Anti-IL-4 Reference Antibody (pascolizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Purity

    >95 %

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Therapeutic Agents by Target and Mechanism: IL-4 inhibitors

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Storage

    4 °C,-80 °C

    Storage Comment

    +4°C,-80°C
  • Target

    IL4 (Pascolizumab Biosimilar)

    Alternative Name

    IL-4 (Pascolizumab Biosimilar)

    Target Type

    Biosimilar

    Molecular Weight

    145.5 kDa

    UniProt

    P05112
You are here:
Chat with us!